701 related articles for article (PubMed ID: 18451332)
1. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice.
Thorp E; Cui D; Schrijvers DM; Kuriakose G; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1421-8. PubMed ID: 18451332
[TBL] [Abstract][Full Text] [Related]
2. DBA/2J Haplotype on Distal Chromosome 2 Reduces Mertk Expression, Restricts Efferocytosis, and Increases Susceptibility to Atherosclerosis.
Kayashima Y; Makhanova N; Maeda N
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):e82-e91. PubMed ID: 28473436
[TBL] [Abstract][Full Text] [Related]
3. MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis.
Cai B; Thorp EB; Doran AC; Sansbury BE; Daemen MJ; Dorweiler B; Spite M; Fredman G; Tabas I
J Clin Invest; 2017 Feb; 127(2):564-568. PubMed ID: 28067670
[TBL] [Abstract][Full Text] [Related]
4. Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis.
Ait-Oufella H; Pouresmail V; Simon T; Blanc-Brude O; Kinugawa K; Merval R; Offenstadt G; Lesèche G; Cohen PL; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1429-31. PubMed ID: 18467644
[TBL] [Abstract][Full Text] [Related]
5. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT
Zhang Y; Wang Y; Zhou D; Zhang LS; Deng FX; Shu S; Wang LJ; Wu Y; Guo N; Zhou J; Yuan ZY
Am J Physiol Cell Physiol; 2019 Oct; 317(4):C776-C787. PubMed ID: 31390228
[TBL] [Abstract][Full Text] [Related]
7. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
[TBL] [Abstract][Full Text] [Related]
8. Enhanced efferocytosis of apoptotic cardiomyocytes through myeloid-epithelial-reproductive tyrosine kinase links acute inflammation resolution to cardiac repair after infarction.
Wan E; Yeap XY; Dehn S; Terry R; Novak M; Zhang S; Iwata S; Han X; Homma S; Drosatos K; Lomasney J; Engman DM; Miller SD; Vaughan DE; Morrow JP; Kishore R; Thorp EB
Circ Res; 2013 Sep; 113(8):1004-12. PubMed ID: 23836795
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms and consequences of efferocytosis in advanced atherosclerosis.
Thorp E; Tabas I
J Leukoc Biol; 2009 Nov; 86(5):1089-95. PubMed ID: 19414539
[TBL] [Abstract][Full Text] [Related]
10. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis.
Doran AC; Ozcan L; Cai B; Zheng Z; Fredman G; Rymond CC; Dorweiler B; Sluimer JC; Hsieh J; Kuriakose G; Tall AR; Tabas I
J Clin Invest; 2017 Nov; 127(11):4075-4089. PubMed ID: 28972541
[TBL] [Abstract][Full Text] [Related]
11. MerTK Cleavage on Resident Cardiac Macrophages Compromises Repair After Myocardial Ischemia Reperfusion Injury.
DeBerge M; Yeap XY; Dehn S; Zhang S; Grigoryeva L; Misener S; Procissi D; Zhou X; Lee DC; Muller WA; Luo X; Rothlin C; Tabas I; Thorp EB
Circ Res; 2017 Sep; 121(8):930-940. PubMed ID: 28851810
[TBL] [Abstract][Full Text] [Related]
12. Sonodynamic therapy-induced foam cells apoptosis activates the phagocytic PPARγ-LXRα-ABCA1/ABCG1 pathway and promotes cholesterol efflux in advanced plaque.
Wang H; Yang Y; Sun X; Tian F; Guo S; Wang W; Tian Z; Jin H; Zhang Z; Tian Y
Theranostics; 2018; 8(18):4969-4984. PubMed ID: 30429880
[TBL] [Abstract][Full Text] [Related]
13. Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis.
Wu J; Liu S; Banerjee O; Shi H; Xue B; Ding Z
Theranostics; 2024; 14(6):2427-2441. PubMed ID: 38646649
[No Abstract] [Full Text] [Related]
14. Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis.
Seneviratne AN; Edsfeldt A; Cole JE; Kassiteridi C; Swart M; Park I; Green P; Khoyratty T; Saliba D; Goddard ME; Sansom SN; Goncalves I; Krams R; Udalova IA; Monaco C
Circulation; 2017 Sep; 136(12):1140-1154. PubMed ID: 28698173
[TBL] [Abstract][Full Text] [Related]
15. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.
Sandahl M; Hunter DM; Strunk KE; Earp HS; Cook RS
BMC Dev Biol; 2010 Dec; 10():122. PubMed ID: 21192804
[TBL] [Abstract][Full Text] [Related]
16. Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?
Garbin U; Baggio E; Stranieri C; Pasini A; Manfro S; Mozzini C; Vallerio P; Lipari G; Merigo F; Guidi G; Cominacini L; Fratta Pasini A
Cardiovasc Res; 2013 Jan; 97(1):125-33. PubMed ID: 22997156
[TBL] [Abstract][Full Text] [Related]
17. Macrophage ALDH2 (Aldehyde Dehydrogenase 2) Stabilizing Rac2 Is Required for Efferocytosis Internalization and Reduction of Atherosclerosis Development.
Zhang J; Zhao X; Guo Y; Liu Z; Wei S; Yuan Q; Shang H; Sang W; Cui S; Xu T; Yang K; Guo J; Pan C; Wang J; Pang J; Han T; Chen Y; Xu F
Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):700-716. PubMed ID: 35354308
[TBL] [Abstract][Full Text] [Related]
18. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
Seitz HM; Camenisch TD; Lemke G; Earp HS; Matsushima GK
J Immunol; 2007 May; 178(9):5635-42. PubMed ID: 17442946
[TBL] [Abstract][Full Text] [Related]
19. Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE
Qiu S; Liu J; Chen J; Li Y; Bu T; Li Z; Zhang L; Sun W; Zhou T; Hu W; Yang G; Yuan L; Duan Y; Xing C
J Nanobiotechnology; 2024 Apr; 22(1):178. PubMed ID: 38614985
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of AXL in Bone Marrow-Derived Cells Does Not Affect Advanced Atherosclerotic Lesion Progression.
Subramanian M; Proto JD; Matsushima GK; Tabas I
Sci Rep; 2016 Dec; 6():39111. PubMed ID: 27958361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
